Biotechnology Jobs

• Philadelphia, United States
• US$203,775 – US$339,625 pa
• Director

Provides scientific and strategic leadership for real-world evidence supporting an mRNA vaccine portfolio, with a primary focus on influenza. Shapes evidence generation across late-stage development, launch and post-marketing, leading US post-marketing vaccine effectiveness studies and external academic and data-partner collaborations. Requires deep expertise in influenza epidemiology, real-world data and causal methods, plus influence across a global matrix.

Medicare · EHR

• Waltham, United States
• US$203,775 – US$339,625 pa
• Director

Provides scientific and strategic leadership for real-world evidence supporting an mRNA vaccine portfolio, with a primary focus on influenza. Shapes evidence generation across late-stage development, launch and post-marketing, leading US post-marketing vaccine effectiveness studies and complex external collaborations with academic and healthcare data partners.

Medicare · EHR · Administrative Claims +1

• Leeds
• Director · manages people

Executive leadership role owning QA and regulatory compliance for the Clinical Pharmacology Services unit, covering CPU operations, GMP pharmacy activities and Phase IB/IIA early-phase trials. Sets risk-based quality strategy, inspection readiness and audit programs, leads global matrixed QA teams and represents the company externally on GCP/GMP matters.

• London
• Hybrid
• Director · manages people

Leads the global and US Medical Affairs Neuro-Oncology team, owning medical strategy, evidence generation and launch planning for pipeline and marketed assets. Serves as a key interface between Medical Affairs and R&D, clinical development and commercial functions, representing regional insights in governance forums. Combines people management with hands-on execution across a complex matrix.

• Maidenhead
• Hybrid · 3 days in office
• US$317,000 – US$409,000 pa
• Director · manages people

Leads a cross-functional Clinical Development Team as the lead scientific expert, owning the clinical strategy, plan and medical monitoring for immunoglobulin programs. Accountable for clinical content of regulatory submissions and study documents, and serves as medical monitor across trials in a matrixed environment.

• Opfikon, Switzerland
• Hybrid · 3 days in office
• US$317,000 – US$409,000 pa
• Director · manages people

Leads the cross-functional Clinical Development Team as lead scientific expert, owning the Clinical Development Plan and integrating internal and external contributions into program strategy. Serves as medical monitor, authors key regulatory and study documents, and presents to safety and review committees.

• London
• Hybrid
• Director

Leads medical evaluation of external innovation and business development opportunities across Ipsen's oncology portfolio, assessing unmet need, clinical value and target product profiles. Sits on the Global Oncology Medical Leadership team, shaping cross-asset strategy and preparing new products for integration, while engaging external experts and scientific societies.

ESMO · ASCO · AACR

• London
• Hybrid
• Director · manages people

Leads global medical strategy for the Neurosciences portfolio, primarily Dysport Movement Disorders indications, defining evidence generation plans, registries and investigator-sponsored research. Acts as Medical functional lead on the global Asset Team, chairs the Medical & Evidence Generation Team, and represents Ipsen with KOLs, societies and advocacy groups. Also leads, coaches and develops Global Medical Directors across the organisation.

Dysport

• Cambridge
• Hybrid · 3 days in office
• Director

Lead digital health strategy engagements with AstraZeneca R&D, top pharma and biotechs, shaping operating models and roadmaps across clinical development. Directs project teams on AI and digital solutions such as ePRO/eCOA, wearables and digital biomarkers, building business cases and tracking value realisation. Combines consulting, protocol design support and scaled implementation in a matrixed environment.

ePRO · eCOA · Wearables +1

• Cambridge
• Hybrid · 3 days in office
• Director · manages people

Owns International regulatory strategy for complex cell therapy programs, embedding regional requirements into evidence generation, submissions and labeling. Leads BLA/MAA planning, Health Authority engagements and labeling negotiations, integrating clinical, CMC, safety and commercial input. Also leads a matrix regulatory team, coaching colleagues and shaping policy and process improvements.

BLA · MAA · IND +2

• US - East Coast
• Hybrid
• Director

Oversees an outsourced global data management vendor across CAR T and autoimmune clinical trials, from protocol development through regulatory submission. Manages eCRF standards, data review and QC plans, database release and lock, and inspection readiness, acting as the main liaison between study teams, vendors and functional partners. Based hybrid in the UK or remote on the US East Coast.

eTMF · eCRF · SAS +2

• Welwyn
• Hybrid
• Director

Provides safety science and pharmacovigilance support across the Roche portfolio, covering signal detection, benefit-risk assessment, ICSR case management and aggregate reporting such as DSUR and PBRER. The role also involves preparing CCDS, labelling, RMP and REMS documents and shaping drug safety input into clinical development strategy. Level is set by experience, working with a global team from the Welwyn office.

DSUR · PBRER · CCDS +3

• London
• On-site
• Director
• Permanent

Senior project manager role coordinating a multi-year osteoporosis drug discovery programme across target ID, hit-to-lead, lead optimisation and candidate selection. Involves orchestrating matrixed wet lab, ML, data science and engineering teams plus CROs, managing plans, budgets, risks and governance, and translating scientific objectives into integrated timelines and milestones.

MS Project · Smartsheet · Asana +1

• London
• Hybrid
• Director

Lead global regulatory strategy for renal therapy programs across all development phases, serving as the regulatory representative on cross-functional teams. Drive major submissions such as INDs, NDAs, BLAs and MAAs, and lead health authority interactions, while mentoring regulatory team members. Distinct for its international scope and focus on renal, nephrology and rare disease assets.

IND · CTA · NDA +2

• London
• Hybrid
• Director
• Permanent

Provide scientific leadership across model evaluation and applied use cases, ensuring foundation models translate into real-world drug discovery and translational research workflows. Act as a senior individual contributor and key scientific partner, mentoring junior colleagues and working with Product and Business Development to turn biology and ML into customer-facing deliverables as the team scales.